Article Information
History
- November 1, 2024.
Article Versions
- Version 1 (September 15, 2024 - 19:18).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Noreen Kamal1,12 (noreen.kamal{at}dal.ca),
- ACTEAST Collaborators2,
- Elena A Cora1,
- Simone Alim1,
- Judah Goldstein1,
- David Volders1,
- Shadi Aljendi3,
- Heather Williams4,
- Patrick Fok1,
- Etienne Van Der Linde5,
- Trish Helm-Neima4,
- Renee Cashin5,
- Brian Metcalfe6,
- Julie Savoie7,
- Wendy Simpkin8,
- Cassie Chisholm5,
- Michael D. Hill9,
- Bijoy K Menon10 and
- Stephen J. Phillips11
- 1 Dalhousie University;
- 2 -;
- 3 University of New Brunswick;
- 4 Health PEI;
- 5 NL Health Services;
- 6 Medflight NL;
- 7 Vitalité Health Network;
- 8 Nova Scotia Health;
- 9 University of Calgary, Cumming School of Medicine;
- 10 University of Calgary, Hotchkiss Brain Institute, Calgary Stroke Program;
- 11 Dalhousie Univ
- ↵* Corresponding author; email: noreen.kamal{at}dal.ca
Posted November 01, 2024.
Improving Access and Efficiency of Acute Ischemic Stroke Treatment Across Four Canadian Provinces: A Stepped-Wedge Trial
